Company / Current Assets per Share
AbCellera Biologics Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.46
FY2025
5-year range
$2.46 / $3.62
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#169 of 210
Health Care
What the data says
AbCellera Biologics Inc.'s current assets per share of $2.46 is lower than 80% of companies in the Health Care sector (FY2025). Current Assets per Share has declined for 3 consecutive years, from $3.62 in FY2022 to $2.46 in FY2025.
Based on SEC 10-K filings.
2.46 in FY2025 with a 5-year CAGR of -4.4%.
Declined from $3.04 to $2.46 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -12.1%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $2.46 Sector average $134.38
▼
-98.2% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 4.7% year-over-year.
- Ranks #169 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.46 | -4.7% |
| FY2024 | $2.58 | -15.0% |
| FY2023 | $3.04 | -16.0% |
| FY2022 | $3.62 | +4.9% |
| FY2021 | $3.45 | +11.6% |
| FY2020 | $3.09 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026